Animal drugs, feeds, and related products: New drug applications— Ampicillin trihydrate for sterile suspension; correction,

[Federal Register: September 2, 1998 (Volume 63, Number 170)]

[Rules and Regulations]

[Page 46652]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr02se98-14]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 522

Implantation or Injectable Dosage Form New Animal Drugs; Ampicillin Trihydrate For Sterile Suspension; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.

SUMMARY: The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of August 4, 1998 (63 FR 41419). The document amended the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filedby G. C. Hanford Manufacturing Co. The document published with an incorrect address. This document corrects that error.

EFFECTIVE DATE: September 2, 1998. FOR FURTHER INFORMATION CONTACT: Carolyn C. Harris, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-2994.

SUPPLEMENTARY INFORMATION: In FR Doc. 98-20698, appearing on page 41419, in the Federal Register of August 4, 1998, the following correction is made: On page 41420, in the first column, in the first complete paragraph, beginning in the ninth line, ``12420 Parklawn Dr., rm. 1-23, Rockville, MD 20857'' is corrected to read ``5630 Fishers Lane, rm. 1061, Rockville, MD 20852''.

Dated: August 26, 1998. William K. Hubbard, Associate Commissioner for Policy Coordination.

[FR Doc. 98-23583Filed9-1-98; 8:45 am]

BILLING CODE 4160-01-F